首页|青黄散治疗髓系肿瘤的临床研究进展

青黄散治疗髓系肿瘤的临床研究进展

扫码查看
髓系肿瘤(Myeloid neoplasms)是一组异质性疾病,肿瘤细胞起源于骨髓中具有多向分化潜能的造血干细胞,并出现克隆性增殖。从20世纪70年代中期开始,诸多经典中药方剂,临床运用效果明显,而青黄散作为代表,通过大量临床数据证实该方治疗髓系肿瘤有效,为古方中药的发掘与研究提供指引,然而如何将中医的研究成果科学化、全球化,是机遇也是挑战。
Clinical Research Progress of Qinghuang Powder in the Treatment of Myeloid Tumors
Myeloid neoplasms are heterogeneous diseases in which myeloid neoplasms are derived from hematopoietic stem cells with the potential for multidifferentiation and clonal proliferation in the bone marrow.Since the mid-1970s,many classical Chinese medicine prescriptions have shown obvious clinical application effects,and Qinghuang SAN,as a representative,has proved its effectiveness in the treatment of myeloid tumors through a large number of clinical data,providing guidance for the dis-covery and research of ancient Chinese medicine.However,how to scientize and globalize the research results of Chinese medi-cine is both an opportunity and a challenge.

qinghuang sanmyeloid tumorinheritancedevelop-ment

邓来军、董杨、刘丽娟、周超、孙伟国、孙长岗

展开 >

潍坊市中医院,山东 潍坊 261000

安丘海吉亚医院,山东 安丘 262124

青黄散 髓系肿瘤 传承 发展

国家自然科学基金山东省中医药科技项目

821742222021M088

2024

实用中医内科杂志
辽宁省中医药学会,中华中医药学会,辽宁省中医药研究院

实用中医内科杂志

影响因子:0.421
ISSN:1671-7813
年,卷(期):2024.38(4)
  • 43